NEMOLIZUMAB-ILTO

NEMOLIZUMAB-ILTO was reported 15930 times

NEMOLIZUMAB-ILTO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSKALAEMIA 1 0.1667
1 BREAST CYST RUPTURE 1 0.0833
2 NEURODERMATITIS 306 0.0821
3 PARADOXICAL SKIN REACTION 3 0.0682
4 ECZEMA WEEPING 8 0.0611
5 ECZEMA NUMMULAR 25 0.0511
6 DEVICE MALFUNCTION 2529 0.0360
7 STAPHYLOCOCCAL IMPETIGO 2 0.0351
8 TICK-BORNE FEVER 2 0.0299
9 SKIN WEEPING 98 0.0274
10 SKIN DISCHARGE 9 0.0236
11 PRODUCT DOSE OMISSION ISSUE 5792 0.0197
12 EYELID DISCOLOURATION 1 0.0196
13 DEVICE USE ERROR 658 0.0189
14 CUTANEOUS T-CELL LYMPHOMA RECURRENT 1 0.0159
15 SKIN TEXTURE ABNORMAL 15 0.0157
16 DEVICE USE ISSUE 269 0.0154
17 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 1 0.0145
18 DEVICE DEFECTIVE 249 0.0144
19 FALLOPIAN TUBE OBSTRUCTION 1 0.0143
20 ECZEMA HERPETICUM 6 0.0130
21 INFECTIVE GLOSSITIS 2 0.0128
22 INTENTIONAL UNDERDOSE 89 0.0122
23 HUMAN BITE 1 0.0120
24 PERIORBITAL IRRITATION 4 0.0117
25 SCABIES 2 0.0117
26 SWELLING OF NOSE 2 0.0116
27 PRODUCT RECONSTITUTION QUALITY ISSUE 10 0.0112
28 BLOOD IMMUNOGLOBULIN E ABNORMAL 1 0.0110
29 DERMATITIS ATOPIC 556 0.0105
30 ADMINISTRATION SITE WOUND 1 0.0101
31 HAND DERMATITIS 7 0.0101
32 DYSHIDROTIC ECZEMA 7 0.0098
33 MALIGNANT MELANOMA STAGE 0 2 0.0096
34 RASH PAPULAR 212 0.0094
35 DEVICE LEAKAGE 403 0.0093
36 EYE NAEVUS 1 0.0088
37 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1578 0.0087
38 MACULAR DETACHMENT 2 0.0083
39 DYSACUSIS 1 0.0081
40 ECZEMA 420 0.0080
41 DERMATITIS EXFOLIATIVE GENERALISED 27 0.0078
42 ITCHING SCAR 1 0.0078
43 SKIN DISCOMFORT 20 0.0074
44 SKIN HYPOPIGMENTATION 12 0.0068
45 INCORRECT DOSE ADMINISTERED 1544 0.0068
46 DACRYOCYSTITIS 1 0.0065
47 IMPLANT SITE WARMTH 1 0.0065
48 SKIN MASS 42 0.0063
49 PRODUCT DOSE CONFUSION 2 0.0056
50 INJECTION SITE ECZEMA 1 0.0052
51 PEMPHIGOID 39 0.0052
52 EYELID EXFOLIATION 4 0.0051
53 STICKY SKIN 2 0.0050
54 KERATITIS FUNGAL 1 0.0048
55 SKIN HYPERPIGMENTATION 41 0.0048
56 SKIN HAEMORRHAGE 70 0.0047
57 SKIN SWELLING 39 0.0045
58 PURULENT DISCHARGE 19 0.0044
59 SKIN HYPERTROPHY 12 0.0043
60 ECZEMA ASTEATOTIC 2 0.0042
61 PUSTULE 10 0.0042
62 SCAB 48 0.0042
63 EAR NEOPLASM MALIGNANT 1 0.0042
64 PRURITUS 1581 0.0041
65 GRANULOMATOUS DERMATITIS 1 0.0041
66 DERMATITIS HERPETIFORMIS 1 0.0041
67 TONGUE ERUPTION 2 0.0040
68 INTENTIONAL PRODUCT USE ISSUE 343 0.0039
69 INFECTION PARASITIC 3 0.0038
70 SKIN WARM 22 0.0038
71 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
72 LIP ERYTHEMA 3 0.0038
73 SKIN FISSURES 73 0.0037
74 ECZEMA INFECTED 1 0.0037
75 MEASLES 2 0.0037
76 PAIN OF SKIN 100 0.0037
77 MORNING SICKNESS 2 0.0037
78 DISCHARGE 5 0.0036
79 SKIN EXFOLIATION 302 0.0036
80 ECZEMA EYELIDS 2 0.0036
81 SKIN WOUND 6 0.0035
82 EAR INFLAMMATION 1 0.0035
83 GENERALISED PUSTULAR PSORIASIS 1 0.0034
84 DRUG EFFECT LESS THAN EXPECTED 51 0.0034
85 EXFOLIATIVE RASH 9 0.0034
86 SKIN INDURATION 7 0.0034
87 CHANGE IN SUSTAINED ATTENTION 1 0.0033
88 INCISION SITE SWELLING 1 0.0033
89 INJECTION SITE HAEMORRHAGE 252 0.0032
90 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
91 ALLERGY TO ARTHROPOD BITE 1 0.0031
92 ANALGESIC THERAPY 1 0.0031
93 NASAL CRUSTING 2 0.0031
94 EYELID RASH 3 0.0031
95 SKIN ULCER 79 0.0031
96 CATHETER SITE IRRITATION 1 0.0030
97 REBOUND ATOPIC DERMATITIS 6 0.0030
98 DERMATITIS PSORIASIFORM 6 0.0029
99 MILIARIA 5 0.0029
100 ADMINISTRATION SITE BRUISE 1 0.0029
101 EAR SWELLING 6 0.0028
102 SKIN EROSION 9 0.0028
103 SKIN TIGHTNESS 13 0.0028
104 DERMATITIS 57 0.0027
105 SKIN DISCOLOURATION 125 0.0027
106 ABSCESS RUPTURE 1 0.0027
107 RASH MACULAR 92 0.0026
108 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
109 DRY SKIN 349 0.0026
110 BLISTER INFECTED 2 0.0026
111 GENITAL ABSCESS 1 0.0025
112 ACNE PUSTULAR 2 0.0024
113 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
114 LICHENIFICATION 1 0.0024
115 RASH 1056 0.0024
116 CARBON MONOXIDE POISONING 1 0.0023
117 RASH ERYTHEMATOUS 111 0.0023
118 THERAPEUTIC RESPONSE SHORTENED 77 0.0023
119 INJECTION SITE INDENTATION 5 0.0023
120 PERIORBITAL SWELLING 13 0.0023
121 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 39 0.0023
122 OTORRHOEA 4 0.0023
123 FUNGAL FOOT INFECTION 1 0.0023
124 BLISTER 128 0.0023
125 PRODUCT OUTER PACKAGING ISSUE 2 0.0022
126 INJECTION SITE DRYNESS 2 0.0022
127 SLEEP DISORDER 154 0.0022
128 HERNIA PAIN 1 0.0022
129 MUSCLE SWELLING 2 0.0022
130 INCISION SITE ERYTHEMA 1 0.0022
131 TONGUE INJURY 2 0.0021
132 AIR EMBOLISM 1 0.0021
133 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
134 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
135 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
136 ANAEMIA VITAMIN B12 DEFICIENCY 1 0.0020
137 ONYCHALGIA 2 0.0020
138 SKIN INFECTION 22 0.0020
139 REBOUND ECZEMA 4 0.0020
140 ORAL MUCOSAL ERUPTION 3 0.0020
141 EYELIDS PRURITUS 6 0.0019
142 DEVICE USE CONFUSION 1 0.0019
143 SWELLING OF EYELID 12 0.0019
144 SKIN ABRASION 9 0.0019
145 FRACTURE PAIN 1 0.0019
146 HORDEOLUM 8 0.0018
147 SKIN WRINKLING 5 0.0018
148 INTERTRIGO 1 0.0018
149 SEBORRHOEIC DERMATITIS 3 0.0018
150 SCRATCH 19 0.0018
151 DERMATITIS EXFOLIATIVE 9 0.0018
152 BONE FRAGMENTATION 1 0.0018
153 SKIN BURNING SENSATION 128 0.0018
154 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
155 INJECTION SITE PAPULE 8 0.0017
156 CHEMICAL BURN 2 0.0017
157 CELLULITIS ORBITAL 1 0.0017
158 PAPULE 12 0.0017
159 COLON CANCER STAGE IV 1 0.0017
160 DERMATILLOMANIA 1 0.0017
161 SKIN LESION 46 0.0017
162 GRANULOMATOSIS WITH POLYANGIITIS 2 0.0017
163 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
164 EYELID SKIN DRYNESS 2 0.0016
165 SEBORRHOEA 6 0.0016
166 XEROSIS 2 0.0016
167 LYMPH NODE PAIN 3 0.0016
168 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
169 BLOOD OSMOLARITY DECREASED 1 0.0016
170 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
171 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
172 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
173 SKIN LACERATION 17 0.0016
174 PRODUCT TEMPERATURE EXCURSION ISSUE 8 0.0016
175 NODULE 20 0.0015
176 INJECTION SITE DISCOLOURATION 19 0.0015
177 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
178 HERPES OPHTHALMIC 2 0.0015
179 ACROCHORDON 2 0.0015
180 SKIN INJURY 5 0.0015
181 EYE INFECTION 17 0.0015
182 LIP EXFOLIATION 2 0.0015
183 FOOD POISONING 8 0.0015
184 ABSCESS NECK 1 0.0015
185 EYELID PAIN 3 0.0015
186 INFLAMMATORY PAIN 1 0.0015
187 CYST RUPTURE 1 0.0015
188 SIALOADENITIS 2 0.0015
189 LICHEN SCLEROSUS 1 0.0015
190 CORNEAL ABRASION 2 0.0015
191 GENITAL SWELLING 1 0.0014
192 URTICARIA 240 0.0014
193 FACIAL DISCOMFORT 1 0.0014
194 INJECTION SITE HYPOAESTHESIA 2 0.0014
195 NAIL INFECTION 2 0.0014
196 ERYTHEMA 284 0.0014
197 PRODUCT PACKAGING ISSUE 13 0.0014
198 DRUG-DISEASE INTERACTION 1 0.0014
199 THERAPEUTIC PRODUCT EFFECT DECREASED 61 0.0014
200 MIDDLE EAR EFFUSION 3 0.0014
201 SENSITIVE SKIN 10 0.0014
202 SKIN IRRITATION 62 0.0014
203 BLISTER RUPTURE 1 0.0013
204 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
205 HEAT STROKE 2 0.0013
206 LIGAMENT SPRAIN 13 0.0013
207 CAUDA EQUINA SYNDROME 1 0.0013
208 INJECTION SITE PARAESTHESIA 2 0.0013
209 HYPERSENSITIVITY 240 0.0013
210 SCAR 22 0.0013
211 PRURITUS GENITAL 3 0.0013
212 INJECTION SITE INJURY 7 0.0013
213 IMPAIRED QUALITY OF LIFE 18 0.0013
214 NIGHT BLINDNESS 2 0.0012
215 HEAT EXHAUSTION 1 0.0012
216 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
217 FUNGAL SKIN INFECTION 5 0.0012
218 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 88 0.0012
219 SHOULDER FRACTURE 2 0.0012
220 GUTTATE PSORIASIS 1 0.0012
221 ERYTHRODERMIC PSORIASIS 1 0.0012
222 GIANT CELL ARTERITIS 1 0.0012
223 SKIN PLAQUE 10 0.0012
224 INFECTED BITE 1 0.0012
225 CRANIOFACIAL FRACTURE 1 0.0012
226 CONCUSSION 9 0.0012
227 TONGUE COATED 2 0.0012
228 FORMICATION 8 0.0011
229 LACK OF INJECTION SITE ROTATION 2 0.0011
230 ALOPECIA AREATA 2 0.0011
231 SWELLING FACE 73 0.0011
232 QUALITY OF LIFE DECREASED 15 0.0011
233 MYALGIA 186 0.0011
234 CONJUNCTIVITIS 20 0.0011
235 TRICHORRHEXIS 3 0.0011
236 OCULAR DISCOMFORT 12 0.0011
237 PRODUCT PREPARATION ISSUE 7 0.0011
238 INJECTION SITE ULCER 1 0.0011
239 EYE DISCHARGE 11 0.0011
240 SKIN ATROPHY 6 0.0010
241 INJECTION SITE SCAB 1 0.0010
242 EYELID MARGIN CRUSTING 3 0.0010
243 RASH VESICULAR 5 0.0010
244 ANAL CANCER 1 0.0010
245 INJURY ASSOCIATED WITH DEVICE 21 0.0010
246 INTENTIONAL OVERDOSE 66 0.0010
247 ANIMAL SCRATCH 1 0.0010
248 SKIN PAPILLOMA 4 0.0010
249 ACNE CYSTIC 3 0.0010
250 EAR HAEMORRHAGE 2 0.0010
251 HAND FRACTURE 7 0.0010
252 BUTTERFLY RASH 1 0.0010
253 BENIGN BREAST NEOPLASM 1 0.0010
254 DISCOMFORT 60 0.0010
255 IMPLANT SITE SWELLING 1 0.0010
256 BREAST ABSCESS 1 0.0010
257 TONGUE BITING 2 0.0010
258 WOUND 27 0.0010
259 IMPLANT SITE ERYTHEMA 1 0.0010
260 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
261 LIQUID PRODUCT PHYSICAL ISSUE 7 0.0010
262 MUSCLE FATIGUE 4 0.0009
263 PERIPHERAL SWELLING 145 0.0009
264 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
265 IDIOPATHIC URTICARIA 1 0.0009
266 AMAUROSIS FUGAX 1 0.0009
267 ERYTHEMA OF EYELID 5 0.0009
268 CHAPPED LIPS 4 0.0009
269 INFUSION SITE MASS 1 0.0009
270 EYE SWELLING 34 0.0009
271 DANDRUFF 2 0.0009
272 TEMPERATURE REGULATION DISORDER 2 0.0009
273 EYE PRURITUS 30 0.0009
274 GENERALISED OEDEMA 11 0.0009
275 FURUNCLE 7 0.0009
276 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
277 ILLNESS 90 0.0009
278 ARTHRITIS INFECTIVE 4 0.0009
279 ARTHRALGIA 357 0.0009
280 BLADDER OPERATION 1 0.0009
281 BACTERIAL INFECTION 16 0.0009
282 INJECTION SITE DISCOMFORT 9 0.0009
283 GROIN ABSCESS 1 0.0008
284 INGROWING NAIL 2 0.0008
285 INJECTION SITE BRUISING 67 0.0008
286 PRODUCT PRESCRIBING ERROR 20 0.0008
287 COCCIDIOIDOMYCOSIS 1 0.0008
288 DEVICE BREAKAGE 34 0.0008
289 WEIGHT ABNORMAL 2 0.0008
290 EYE DISORDER 27 0.0008
291 RETINAL TEAR 2 0.0008
292 ARTHROPOD BITE 6 0.0008
293 HEADACHE 505 0.0008
294 ALLERGY TO CHEMICALS 1 0.0008
295 DRY EYE 40 0.0008
296 REBOUND EFFECT 9 0.0008
297 OSTEITIS 2 0.0008
298 LIP DISCOLOURATION 1 0.0008
299 HYPERAESTHESIA TEETH 1 0.0008
300 DERMATOMYOSITIS 2 0.0008
301 EAR INFECTION 21 0.0008
302 FACIAL PAIN 7 0.0008
303 FOOD ALLERGY 6 0.0008
304 BILIARY OBSTRUCTION 1 0.0008
305 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 14 0.0008
306 LYMPHADENOPATHY 27 0.0008
307 SKIN ODOUR ABNORMAL 3 0.0008
308 ACCIDENT 9 0.0008
309 ANIMAL BITE 2 0.0007
310 BLEPHARITIS 3 0.0007
311 INJECTION SITE DISCHARGE 4 0.0007
312 CONDITION AGGRAVATED 224 0.0007
313 CELLULITIS 37 0.0007
314 EYE INFLAMMATION 7 0.0007
315 IMMUNOGLOBULINS DECREASED 1 0.0007
316 HEAD TITUBATION 1 0.0007
317 INFLUENZA 81 0.0007
318 RASH MORBILLIFORM 2 0.0007
319 CHOLECYSTITIS INFECTIVE 2 0.0007
320 DRUG INEFFECTIVE 947 0.0007
321 SERUM SICKNESS 2 0.0007
322 ELECTRIC SHOCK SENSATION 2 0.0007
323 SINUS DISORDER 14 0.0007
324 DIABETIC FOOT INFECTION 1 0.0007
325 BLOOD ELECTROLYTES DECREASED 1 0.0007
326 LOCALISED INFECTION 17 0.0007
327 BRAIN FOG 11 0.0007
328 PRODUCT DISPENSING ISSUE 3 0.0007
329 RASH PRURITIC 38 0.0007
330 LIP PAIN 2 0.0007
331 MOUTH SWELLING 4 0.0007
332 RASH PUSTULAR 5 0.0007
333 DIVERTICULUM INTESTINAL 3 0.0007
334 PULMONARY PAIN 2 0.0007
335 DARK CIRCLES UNDER EYES 1 0.0007
336 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
337 IMPETIGO 1 0.0007
338 SUNBURN 5 0.0007
339 FOLLICULITIS 7 0.0007
340 HYPOSMIA 1 0.0007
341 ADHESION 1 0.0007
342 INJECTION SITE VESICLES 4 0.0007
343 THERAPEUTIC RESPONSE DECREASED 40 0.0007
344 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
345 INJECTION SITE URTICARIA 16 0.0007
346 INJECTION SITE RASH 20 0.0007
347 EYE ALLERGY 1 0.0006
348 INJECTION SITE PAIN 198 0.0006
349 ROSACEA 3 0.0006
350 BLOOD BLISTER 2 0.0006
351 BACTERIAL VAGINOSIS 1 0.0006
352 STAPHYLOCOCCAL INFECTION 21 0.0006
353 EXPOSURE TO TOXIC AGENT 2 0.0006
354 DERMATITIS CONTACT 7 0.0006
355 PHARYNGEAL SWELLING 6 0.0006
356 OCULAR HYPERAEMIA 29 0.0006
357 MIGRAINE 58 0.0006
358 INJECTION SITE INFLAMMATION 3 0.0006
359 ARTHROPOD STING 1 0.0006
360 EOSINOPHIL COUNT INCREASED 5 0.0006
361 VULVOVAGINAL PRURITUS 3 0.0006
362 FOOD AVERSION 1 0.0006
363 EXPOSURE TO SARS-COV-2 1 0.0006
364 BLADDER NEOPLASM 1 0.0006
365 WOUND COMPLICATION 2 0.0006
366 CERVICAL VERTEBRAL FRACTURE 2 0.0006
367 FUNGAL INFECTION 19 0.0006
368 GROIN PAIN 5 0.0006
369 PRESCRIBED OVERDOSE 11 0.0006
370 GASTROINTESTINAL OEDEMA 1 0.0006
371 BREAST CYST 1 0.0006
372 INDURATION 1 0.0006
373 GASTROINTESTINAL INFECTION 5 0.0006
374 HERPES ZOSTER 32 0.0006
375 ACNE 42 0.0006
376 ACCIDENTAL EXPOSURE TO PRODUCT 57 0.0006
377 PRODUCT PRESCRIBING ISSUE 12 0.0006
378 SINUSITIS 56 0.0005
379 BODY TEMPERATURE ABNORMAL 1 0.0005
380 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
381 PRODUCT STORAGE ERROR 47 0.0005
382 INJECTION SITE WARMTH 11 0.0005
383 BLADDER SPASM 1 0.0005
384 IMMUNE SYSTEM DISORDER 7 0.0005
385 PARANASAL SINUS DISCOMFORT 2 0.0005
386 LIP DISORDER 1 0.0005
387 PRODUCT STORAGE ISSUE 2 0.0005
388 ROAD TRAFFIC ACCIDENT 22 0.0005
389 ADRENAL DISORDER 1 0.0005
390 ANKLE FRACTURE 8 0.0005
391 EPIGASTRIC DISCOMFORT 2 0.0005
392 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
393 JOINT NOISE 1 0.0005
394 PLEURISY 3 0.0005
395 SINUS HEADACHE 3 0.0005
396 INTRACRANIAL ANEURYSM 2 0.0005
397 CARDIAC DISCOMFORT 1 0.0005
398 LIBIDO INCREASED 1 0.0005
399 FEEDING DISORDER 10 0.0005
400 INJECTION SITE PRURITUS 33 0.0005
401 PRODUCT PREPARATION ERROR 10 0.0005
402 CHEST INJURY 1 0.0005
403 ABNORMAL SENSATION IN EYE 2 0.0005
404 TENSION HEADACHE 2 0.0005
405 INFUSION SITE BRUISING 1 0.0005
406 MUSCLE STRAIN 4 0.0005
407 JOINT STIFFNESS 12 0.0005
408 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
409 LIMB MASS 1 0.0005
410 COLONOSCOPY 1 0.0005
411 LIGAMENT RUPTURE 2 0.0005
412 BLOOD PRESSURE ABNORMAL 9 0.0005
413 ACCIDENT AT WORK 1 0.0005
414 HEAD DISCOMFORT 8 0.0005
415 EYE IRRITATION 26 0.0005
416 DRUG ERUPTION 8 0.0005
417 GASTROINTESTINAL ULCER 1 0.0005
418 CALCINOSIS 1 0.0004
419 MENINGITIS ASEPTIC 2 0.0004
420 POSTOPERATIVE WOUND INFECTION 3 0.0004
421 ULCER HAEMORRHAGE 3 0.0004
422 HEAD INJURY 14 0.0004
423 LIMB INJURY 12 0.0004
424 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
425 HIDRADENITIS 4 0.0004
426 RETINAL DETACHMENT 4 0.0004
427 DROOLING 3 0.0004
428 MUSCLE TIGHTNESS 7 0.0004
429 LICHEN PLANUS 1 0.0004
430 PRODUCT DISTRIBUTION ISSUE 4 0.0004
431 IMPLANT SITE INFECTION 1 0.0004
432 FEELING OF DESPAIR 2 0.0004
433 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
434 WRIST FRACTURE 5 0.0004
435 SWELLING 39 0.0004
436 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
437 NEEDLE ISSUE 12 0.0004
438 AUTOIMMUNE DISORDER 4 0.0004
439 HAEMATOLOGICAL INFECTION 1 0.0004
440 DERMAL CYST 1 0.0004
441 CONTUSION 39 0.0004
442 INJECTION SITE ERYTHEMA 50 0.0004
443 EYELID IRRITATION 1 0.0004
444 PRODUCT ADMINISTRATION ERROR 8 0.0004
445 DEVICE FAILURE 6 0.0004
446 INJECTION SITE SWELLING 30 0.0004
447 SKIN DISORDER 13 0.0004
448 PRODUCT COLOUR ISSUE 2 0.0004
449 LIMB DISCOMFORT 12 0.0004
450 DRUG TITRATION ERROR 1 0.0004
451 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
452 INJECTION SITE INDURATION 5 0.0004
453 FAILURE TO THRIVE 2 0.0004
454 ANGIOEDEMA 17 0.0004
455 TENDERNESS 4 0.0004
456 TONSILLITIS 2 0.0004
457 JOINT SWELLING 46 0.0004
458 NASOPHARYNGITIS 70 0.0004
459 TOOTH INFECTION 5 0.0004
460 JOINT DISLOCATION 4 0.0004
461 RENAL PAIN 4 0.0004
462 JOINT INJURY 8 0.0004
463 MUSCLE DISORDER 3 0.0004
464 EXTRA DOSE ADMINISTERED 15 0.0004
465 CHEILITIS 2 0.0004
466 PHARYNGITIS STREPTOCOCCAL 4 0.0004
467 FOOT FRACTURE 7 0.0004
468 EAR CONGESTION 1 0.0004
469 BACK DISORDER 6 0.0004
470 INFLAMMATION 19 0.0004
471 PHOTOSENSITIVITY REACTION 6 0.0004
472 HYPERKERATOSIS 2 0.0004
473 EOSINOPHILIC OESOPHAGITIS 1 0.0004
474 DIVERTICULITIS 10 0.0004
475 ORAL HERPES 7 0.0004
476 VISION BLURRED 49 0.0004
477 ALOPECIA 70 0.0004
478 FACE OEDEMA 6 0.0004
479 BLINDNESS UNILATERAL 5 0.0004
480 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
481 INJECTION SITE MASS 13 0.0004
482 HEART VALVE INCOMPETENCE 1 0.0003
483 EXPOSURE VIA SKIN CONTACT 9 0.0003
484 HERPES VIRUS INFECTION 2 0.0003
485 FIBULA FRACTURE 1 0.0003
486 VISUAL IMPAIRMENT 43 0.0003
487 DIPLOPIA 9 0.0003
488 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
489 EYELID OEDEMA 4 0.0003
490 BILIARY COLIC 1 0.0003
491 FEELING HOT 21 0.0003
492 EOSINOPHILIA 6 0.0003
493 IMMUNOSUPPRESSION 3 0.0003
494 DECREASED INTEREST 2 0.0003
495 CATARACT OPERATION 2 0.0003
496 BLOOD CULTURE POSITIVE 1 0.0003
497 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
498 VIRAL INFECTION 11 0.0003
499 EYE INJURY 1 0.0003
500 IRITIS 1 0.0003
501 KERATITIS 1 0.0003
502 DYSCHEZIA 1 0.0003
503 IMPAIRED WORK ABILITY 7 0.0003
504 ASTHMA 37 0.0003
505 DIABETIC FOOT 1 0.0003
506 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
507 PIGMENTATION DISORDER 2 0.0003
508 LYMPHOMA 5 0.0003
509 TENDONITIS 5 0.0003
510 INJECTION SITE HYPERSENSITIVITY 1 0.0003
511 PAIN 196 0.0003
512 SQUAMOUS CELL CARCINOMA 3 0.0003
513 INFUSION SITE PRURITUS 1 0.0003
514 BREAST CANCER RECURRENT 1 0.0003
515 PHOTOPSIA 2 0.0003
516 FOREIGN BODY SENSATION IN EYES 2 0.0003
517 SCIATICA 5 0.0003
518 OROPHARYNGEAL PAIN 29 0.0003
519 FALL 104 0.0003
520 LOWER LIMB FRACTURE 6 0.0003
521 HERPES SIMPLEX 2 0.0003
522 NASAL CONGESTION 18 0.0003
523 VITREOUS FLOATERS 3 0.0003
524 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
525 TREATMENT FAILURE 25 0.0003
526 PRESCRIBED UNDERDOSE 6 0.0003
527 POST-TRAUMATIC STRESS DISORDER 2 0.0003
528 BRONCHITIS 22 0.0003
529 WRONG PRODUCT ADMINISTERED 2 0.0003
530 FLUID RETENTION 15 0.0003
531 TEMPERATURE INTOLERANCE 3 0.0003
532 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
533 BLOOD CREATININE ABNORMAL 1 0.0003
534 HAIR GROWTH ABNORMAL 2 0.0003
535 ORAL DISCOMFORT 4 0.0003
536 FEELING COLD 8 0.0003
537 AORTIC STENOSIS 1 0.0003
538 WEIGHT FLUCTUATION 3 0.0003
539 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
540 CARPAL TUNNEL SYNDROME 4 0.0003
541 INTENTIONAL PRODUCT MISUSE 25 0.0003
542 EAR PRURITUS 1 0.0003
543 SKIN REACTION 4 0.0003
544 EYE PAIN 16 0.0003
545 NEPHROLITHIASIS 13 0.0003
546 CYSTITIS 9 0.0003
547 CHILLS 33 0.0003
548 FEAR OF INJECTION 2 0.0003
549 HYPERSOMNIA 8 0.0003
550 VERTIGO 17 0.0003
551 DERMATITIS BULLOUS 2 0.0003
552 TOOTHACHE 5 0.0003
553 URINARY TRACT INFECTION 47 0.0003
554 BONE PAIN 16 0.0003
555 FOOD INTOLERANCE 1 0.0003
556 MUSCLE SPASMS 50 0.0003
557 PAIN IN EXTREMITY 80 0.0003
558 BLINDNESS TRANSIENT 2 0.0003
559 OEDEMA PERIPHERAL 33 0.0003
560 LIP SWELLING 9 0.0003
561 NERVE INJURY 3 0.0003
562 HYPERACUSIS 1 0.0003
563 IMMUNODEFICIENCY 4 0.0003
564 ORAL PAIN 6 0.0003
565 ABDOMINAL PAIN UPPER 55 0.0003
566 BACK PAIN 62 0.0003
567 CHRONIC SINUSITIS 1 0.0003
568 PRODUCT USE IN UNAPPROVED INDICATION 66 0.0003
569 BLOOD SODIUM DECREASED 5 0.0003
570 PAROSMIA 2 0.0003
571 LACRIMATION INCREASED 8 0.0003
572 DEHYDRATION 35 0.0003
573 SLEEP APNOEA SYNDROME 5 0.0003
574 INCREASED APPETITE 5 0.0003
575 GASTRIC INFECTION 1 0.0003
576 HIP ARTHROPLASTY 4 0.0003
577 MADAROSIS 3 0.0003
578 HAEMORRHAGE 27 0.0003
579 BLOOD IRON DECREASED 3 0.0003
580 ULCER 4 0.0003
581 HYPERHIDROSIS 32 0.0002
582 NIGHT SWEATS 8 0.0002
583 FRUSTRATION TOLERANCE DECREASED 2 0.0002
584 NEURALGIA 6 0.0002
585 POST PROCEDURAL INFECTION 2 0.0002
586 ARTHRITIS BACTERIAL 1 0.0002
587 SPINAL OPERATION 3 0.0002
588 RIB FRACTURE 5 0.0002
589 PHARYNGITIS 3 0.0002
590 CYST 3 0.0002
591 MENSTRUAL DISORDER 2 0.0002
592 MUSCLE INJURY 2 0.0002
593 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
594 GAIT INABILITY 8 0.0002
595 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
596 PSORIASIS 31 0.0002
597 RENAL DISORDER 11 0.0002
598 INFECTION 34 0.0002
599 ABSCESS LIMB 1 0.0002
600 HEPATIC PAIN 1 0.0002
601 RESPIRATORY DISORDER 7 0.0002
602 PRODUCT CONTAINER ISSUE 2 0.0002
603 PSEUDOMONAS INFECTION 2 0.0002
604 IRRITABLE BOWEL SYNDROME 5 0.0002
605 NECK PAIN 13 0.0002
606 MUSCULOSKELETAL DISCOMFORT 4 0.0002
607 RESPIRATORY TRACT INFECTION 6 0.0002
608 BONE CANCER 1 0.0002
609 PRODUCT DISPENSING ERROR 5 0.0002
610 NAIL DISORDER 2 0.0002
611 ORAL CANDIDIASIS 3 0.0002
612 PULMONARY CONGESTION 3 0.0002
613 PRODUCT COMMUNICATION ISSUE 2 0.0002
614 GINGIVAL SWELLING 1 0.0002
615 PURPURA 2 0.0002
616 EYE HAEMORRHAGE 3 0.0002
617 DIZZINESS 111 0.0002
618 IRON DEFICIENCY 1 0.0002
619 DYSPHONIA 13 0.0002
620 LIP DRY 2 0.0002
621 PERIPHERAL COLDNESS 3 0.0002
622 DISEASE COMPLICATION 1 0.0002
623 EAR DISORDER 1 0.0002
624 EYE OPERATION 1 0.0002
625 NERVE COMPRESSION 2 0.0002
626 RHINORRHOEA 14 0.0002
627 ARTHRITIS 17 0.0002
628 MALAISE 93 0.0002
629 HEPATOCELLULAR INJURY 3 0.0002
630 FRACTURE 4 0.0002
631 ENDOMETRIOSIS 1 0.0002
632 LIMB OPERATION 1 0.0002
633 BLOOD PRESSURE FLUCTUATION 5 0.0002
634 OFF LABEL USE 182 0.0002
635 HUMERUS FRACTURE 1 0.0002
636 ANOSMIA 3 0.0002
637 GUILLAIN-BARRE SYNDROME 1 0.0002
638 EAR PAIN 4 0.0002
639 PRESYNCOPE 5 0.0002
640 GASTROENTERITIS 3 0.0002
641 MUSCULOSKELETAL STIFFNESS 18 0.0002
642 HAEMORRHOIDS 4 0.0002
643 KIDNEY INFECTION 4 0.0002
644 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
645 PARAESTHESIA 32 0.0002
646 COUGH 57 0.0002
647 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
648 INFLAMMATORY MARKER INCREASED 1 0.0002
649 ANEURYSM 1 0.0002
650 UPPER LIMB FRACTURE 4 0.0002
651 AGEUSIA 5 0.0002
652 OVARIAN CYST 2 0.0002
653 ERYSIPELAS 1 0.0002
654 INSOMNIA 53 0.0002
655 EYELID PTOSIS 2 0.0002
656 DRY THROAT 2 0.0002
657 TOOTH ABSCESS 2 0.0002
658 INFLUENZA LIKE ILLNESS 16 0.0002
659 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
660 VENTRICULAR EXTRASYSTOLES 2 0.0002
661 SWOLLEN TONGUE 6 0.0002
662 ACCIDENTAL OVERDOSE 7 0.0002
663 DEVICE ISSUE 17 0.0002
664 RESPIRATORY TRACT CONGESTION 3 0.0002
665 ANORECTAL DISCOMFORT 1 0.0002
666 COMPRESSION FRACTURE 1 0.0002
667 THROMBOSIS 15 0.0002
668 BREAST CANCER METASTATIC 2 0.0002
669 ABDOMINAL DISCOMFORT 31 0.0002
670 COLITIS 7 0.0002
671 OEDEMA 10 0.0002
672 CHEST PAIN 34 0.0002
673 MULTIPLE FRACTURES 3 0.0002
674 FAECALOMA 1 0.0002
675 PNEUMONIA 59 0.0002
676 ASTHENOPIA 1 0.0002
677 LIVER DISORDER 8 0.0002
678 ARTHROPATHY 10 0.0002
679 NEOPLASM MALIGNANT 12 0.0002
680 ANGIOPATHY 1 0.0002
681 THROAT IRRITATION 8 0.0002
682 IMPAIRED DRIVING ABILITY 2 0.0002
683 INTERNAL HAEMORRHAGE 2 0.0002
684 CARDIAC VALVE DISEASE 1 0.0002
685 BLOOD URIC ACID INCREASED 1 0.0002
686 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
687 GAIT DISTURBANCE 33 0.0002
688 BURNING SENSATION 12 0.0002
689 HYPOVOLAEMIA 1 0.0002
690 SPINAL PAIN 2 0.0002
691 HYPERCHLORHYDRIA 1 0.0002
692 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
693 ENERGY INCREASED 1 0.0002
694 BACTERAEMIA 2 0.0002
695 PRODUCTIVE COUGH 8 0.0002
696 MACULAR DEGENERATION 2 0.0002
697 MOBILITY DECREASED 12 0.0002
698 BLOOD POTASSIUM DECREASED 5 0.0002
699 GASTROENTERITIS VIRAL 3 0.0002
700 GANGRENE 1 0.0002
701 OSTEOMYELITIS 3 0.0002
702 COVID-19 29 0.0002
703 FIBROMYALGIA 4 0.0002
704 SEIZURE 19 0.0002
705 DERMATITIS ACNEIFORM 1 0.0002
706 TENDON RUPTURE 2 0.0002
707 THINKING ABNORMAL 3 0.0002
708 FATIGUE 125 0.0002
709 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
710 SECRETION DISCHARGE 2 0.0002
711 PHOTOPHOBIA 3 0.0002
712 DERMATITIS ALLERGIC 2 0.0002
713 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
714 ABDOMINAL PAIN LOWER 4 0.0002
715 DEATH 136 0.0002
716 INJECTION SITE IRRITATION 2 0.0002
717 GASTROINTESTINAL DISORDER 14 0.0002
718 GLAUCOMA 3 0.0002
719 HIP FRACTURE 5 0.0002
720 HERNIA 3 0.0002
721 CARDIAC FLUTTER 1 0.0002
722 ANGINA UNSTABLE 1 0.0002
723 TINNITUS 7 0.0002
724 BEDRIDDEN 2 0.0002
725 WHEEZING 9 0.0002
726 CARDIAC DISORDER 14 0.0001
727 HAIR TEXTURE ABNORMAL 2 0.0001
728 JOINT RANGE OF MOTION DECREASED 2 0.0001
729 BREAST MASS 1 0.0001
730 FREQUENT BOWEL MOVEMENTS 4 0.0001
731 SINUS CONGESTION 2 0.0001
732 TASTE DISORDER 3 0.0001
733 NAUSEA 117 0.0001
734 FLUSHING 15 0.0001
735 WEIGHT INCREASED 33 0.0001
736 HOT FLUSH 11 0.0001
737 JOINT EFFUSION 1 0.0001
738 ANAPHYLACTIC REACTION 8 0.0001
739 APHONIA 2 0.0001
740 BLOOD TEST ABNORMAL 2 0.0001
741 LYMPHOPENIA 2 0.0001
742 SEASONAL ALLERGY 2 0.0001
743 FLATULENCE 8 0.0001
744 CEREBRAL HAEMORRHAGE 5 0.0001
745 HYPOACUSIS 6 0.0001
746 SKIN CANCER 3 0.0001
747 DIARRHOEA 89 0.0001
748 MENTAL DISORDER 6 0.0001
749 HYPOKINESIA 2 0.0001
750 FEELING ABNORMAL 33 0.0001
751 BLOOD PRESSURE INCREASED 21 0.0001
752 ASTHENIA 51 0.0001
753 CEREBRAL DISORDER 1 0.0001
754 CATARACT 8 0.0001
755 GLOSSODYNIA 3 0.0001
756 NERVOUSNESS 7 0.0001
757 TREMOR 22 0.0001
758 DYSPNOEA 75 0.0001
759 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
760 HEPATOCELLULAR CARCINOMA 1 0.0001
761 INJECTION SITE REACTION 9 0.0001
762 MUSCLE TWITCHING 3 0.0001
763 CEREBROVASCULAR ACCIDENT 22 0.0001
764 THYROID DISORDER 2 0.0001
765 FEMUR FRACTURE 4 0.0001
766 APHTHOUS ULCER 1 0.0001
767 EJECTION FRACTION DECREASED 2 0.0001
768 BASAL CELL CARCINOMA 2 0.0001
769 AFFECTIVE DISORDER 1 0.0001
770 CHEST DISCOMFORT 13 0.0001
771 GINGIVAL PAIN 1 0.0001
772 BLOOD DISORDER 1 0.0001
773 BLOOD POTASSIUM INCREASED 2 0.0001
774 LUNG DISORDER 6 0.0001
775 LETHARGY 7 0.0001
776 ESCHERICHIA INFECTION 1 0.0001
777 PALPITATIONS 14 0.0001
778 SURGERY 7 0.0001
779 CANDIDA INFECTION 2 0.0001
780 HAEMATEMESIS 3 0.0001
781 HEMIPARESIS 2 0.0001
782 SEPSIS 13 0.0001
783 PYREXIA 40 0.0001
784 SPEECH DISORDER 6 0.0001
785 MUSCULAR WEAKNESS 13 0.0001
786 GASTRITIS 3 0.0001
787 HYPOAESTHESIA 17 0.0001
788 COLD SWEAT 2 0.0001
789 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
790 GOUT 2 0.0001
791 DISTURBANCE IN ATTENTION 6 0.0001
792 ANAL INCONTINENCE 1 0.0001
793 HEART RATE INCREASED 11 0.0001
794 DRY MOUTH 9 0.0001
795 THROAT TIGHTNESS 3 0.0001
796 SYNCOPE 11 0.0001
797 RESTLESSNESS 4 0.0001
798 ANXIETY 31 0.0001
799 INCREASED TENDENCY TO BRUISE 1 0.0001
800 MENTAL STATUS CHANGES 3 0.0001
801 ABDOMINAL PAIN 25 0.0001
802 HEPATIC STEATOSIS 2 0.0001
803 BLOOD CHOLESTEROL INCREASED 5 0.0001
804 ERYTHEMA MULTIFORME 1 0.0001
805 MIDDLE INSOMNIA 2 0.0001
806 DIARRHOEA HAEMORRHAGIC 1 0.0001
807 FLANK PAIN 1 0.0001
808 BLOOD URINE PRESENT 2 0.0001
809 GASTRIC ULCER 2 0.0001
810 DIABETES MELLITUS 8 0.0001
811 ANGINA PECTORIS 3 0.0001
812 POST PROCEDURAL COMPLICATION 2 0.0001
813 PANCREATIC CARCINOMA 3 0.0001
814 ERUCTATION 2 0.0001
815 DIZZINESS POSTURAL 1 0.0001
816 CHOKING 2 0.0001
817 VOMITING 48 0.0001
818 COELIAC DISEASE 1 0.0001
819 BODY TEMPERATURE DECREASED 1 0.0001
820 HYPOTONIA 1 0.0001
821 SPINAL FRACTURE 2 0.0001
822 CARDIAC FAILURE 8 0.0001
823 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
824 FULL BLOOD COUNT DECREASED 2 0.0001
825 PRODUCT PHYSICAL ISSUE 2 0.0001
826 EMPHYSEMA 1 0.0001
827 BLINDNESS 4 0.0001
828 BODY TEMPERATURE INCREASED 2 0.0001
829 MYOCARDIAL INFARCTION 17 0.0001
830 EAR DISCOMFORT 1 0.0001
831 HELICOBACTER INFECTION 1 0.0001
832 NERVOUS SYSTEM DISORDER 3 0.0001
833 POLLAKIURIA 4 0.0001
834 UNDERDOSE 7 0.0001
835 NEUROPATHY PERIPHERAL 9 0.0001
836 PANCREATITIS 5 0.0001
837 FULL BLOOD COUNT ABNORMAL 1 0.0001
838 MOOD SWINGS 3 0.0001
839 EATING DISORDER 2 0.0001
840 BREAST PAIN 1 0.0001
841 EPISTAXIS 7 0.0001
842 HEREDITARY ANGIOEDEMA 1 0.0001
843 WEIGHT DECREASED 26 0.0001
844 FAECES DISCOLOURED 2 0.0001
845 BIPOLAR DISORDER 1 0.0001
846 BACK INJURY 1 0.0001
847 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
848 DYSPEPSIA 9 0.0001
849 IMPAIRED HEALING 3 0.0001
850 ASPIRATION 1 0.0001
851 DECREASED APPETITE 21 0.0001
852 BLOOD PRESSURE DECREASED 6 0.0001
853 RASH MACULO-PAPULAR 2 0.0001
854 HEPATOTOXICITY 2 0.0001
855 HYPERTENSION 19 0.0001
856 SOMNOLENCE 18 0.0001
857 SNEEZING 2 0.0001
858 PANCREATITIS ACUTE 2 0.0001
859 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
860 CHROMATURIA 2 0.0001
861 HEPATIC ENZYME INCREASED 6 0.0001
862 SUICIDAL IDEATION 8 0.0001
863 ABDOMINAL DISTENSION 9 0.0001
864 LOSS OF CONSCIOUSNESS 11 0.0001
865 INJURY 6 0.0001
866 BLOOD GLUCOSE DECREASED 4 0.0001
867 HEPATIC CANCER 2 0.0001
868 CRYING 3 0.0001
869 BURSITIS 1 0.0001
870 PANIC ATTACK 3 0.0001
871 DYSURIA 3 0.0001
872 BALANCE DISORDER 7 0.0001
873 ABNORMAL WEIGHT GAIN 1 0.0001
874 EXPOSURE DURING PREGNANCY 5 0.0001
875 INTRAOCULAR PRESSURE INCREASED 1 0.0001
876 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
877 CONSTIPATION 17 0.0001
878 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
879 INFUSION SITE PAIN 1 0.0001
880 HIATUS HERNIA 1 0.0001
881 DEPRESSED MOOD 4 0.0001
882 FEAR 2 0.0001
883 DYSPHAGIA 7 0.0001
884 IMPAIRED GASTRIC EMPTYING 1 0.0001
885 DEVICE MECHANICAL ISSUE 1 0.0001
886 CORONARY ARTERY OCCLUSION 1 0.0001
887 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
888 MEMORY IMPAIRMENT 10 0.0001
889 DRUG INTOLERANCE 7 0.0001
890 HUNGER 1 0.0001
891 DEMENTIA 2 0.0001
892 PAIN IN JAW 2 0.0001
893 INTENTIONAL DOSE OMISSION 2 0.0001
894 BRONCHOSPASM 1 0.0001
895 BLOOD GLUCOSE INCREASED 13 0.0001
896 APATHY 1 0.0001
897 DYSSTASIA 2 0.0001
898 URINARY INCONTINENCE 2 0.0001
899 COLON CANCER 1 0.0001
900 PULMONARY OEDEMA 3 0.0001
901 APHASIA 2 0.0001
902 INSURANCE ISSUE 1 0.0001
903 DEVICE RELATED INFECTION 1 0.0001
904 ACUTE MYELOID LEUKAEMIA 1 0.0001
905 ABSCESS 1 0.0001
906 MOVEMENT DISORDER 2 0.0001
907 CIRCULATORY COLLAPSE 1 0.0001
908 THERAPY CESSATION 3 0.0001
909 AMENORRHOEA 1 0.0001
910 ADVERSE DRUG REACTION 5 0.0001
911 BLOOD GLUCOSE ABNORMAL 1 0.0001
912 HEPATIC CIRRHOSIS 1 0.0001
913 DYSPNOEA EXERTIONAL 2 0.0001
914 INTESTINAL OBSTRUCTION 2 0.0001
915 DEPRESSION 12 0.0001
916 FEELING JITTERY 1 0.0001
917 ATRIAL FIBRILLATION 5 0.0001
918 DISABILITY 1 0.0001
919 HYPOTENSION 10 0.0000
920 CARDIAC FAILURE CONGESTIVE 4 0.0000
921 PSORIATIC ARTHROPATHY 2 0.0000
922 LUNG NEOPLASM MALIGNANT 2 0.0000
923 WITHDRAWAL SYNDROME 2 0.0000
924 KNEE ARTHROPLASTY 1 0.0000
925 ANAEMIA 9 0.0000
926 DEEP VEIN THROMBOSIS 3 0.0000
927 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
928 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
929 DEVICE DIFFICULT TO USE 3 0.0000
930 RENAL FAILURE 6 0.0000
931 TACHYCARDIA 4 0.0000
932 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
933 HEART RATE IRREGULAR 1 0.0000
934 DRUG INTERACTION 7 0.0000
935 HYPOKALAEMIA 2 0.0000
936 THERAPY INTERRUPTED 3 0.0000
937 EMOTIONAL DISTRESS 5 0.0000
938 AGITATION 3 0.0000
939 HALLUCINATION 3 0.0000
940 HEPATITIS 1 0.0000
941 ERECTILE DYSFUNCTION 1 0.0000
942 MUSCULOSKELETAL PAIN 2 0.0000
943 ANHEDONIA 1 0.0000
944 BRADYCARDIA 2 0.0000
945 JAUNDICE 1 0.0000
946 TREATMENT NONCOMPLIANCE 2 0.0000
947 HAEMATOCHEZIA 2 0.0000
948 HAEMOPTYSIS 1 0.0000
949 ASCITES 1 0.0000
950 IRRITABILITY 2 0.0000
951 HEPATIC FAILURE 1 0.0000
952 STOMATITIS 2 0.0000
953 HOSPITALISATION 5 0.0000
954 BREAST CANCER 3 0.0000
955 CONFUSIONAL STATE 5 0.0000
956 AMNESIA 2 0.0000
957 EXPIRED PRODUCT ADMINISTERED 1 0.0000
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
959 ANGER 1 0.0000
960 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
961 HAEMOGLOBIN DECREASED 3 0.0000
962 HEART RATE DECREASED 1 0.0000
963 HYPOXIA 1 0.0000
964 PLATELET COUNT DECREASED 3 0.0000
965 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
966 C-REACTIVE PROTEIN INCREASED 1 0.0000
967 DYSARTHRIA 1 0.0000
968 RHEUMATOID ARTHRITIS 3 0.0000
969 DISORIENTATION 1 0.0000
970 ABORTION SPONTANEOUS 1 0.0000
971 DYSKINESIA 1 0.0000
972 OVERDOSE 5 0.0000
973 COLITIS ULCERATIVE 1 0.0000
974 COGNITIVE DISORDER 1 0.0000
975 ARRHYTHMIA 1 0.0000
976 PULMONARY EMBOLISM 2 0.0000
977 COLORECTAL CANCER 1 0.0000
978 HYPOGLYCAEMIA 1 0.0000
979 HYPONATRAEMIA 1 0.0000
980 NO ADVERSE EVENT 3 0.0000
981 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
982 BLOOD CREATININE INCREASED 1 0.0000
983 DYSGEUSIA 1 0.0000
984 DRUG DOSE OMISSION BY DEVICE 1 0.0000
985 CARDIAC ARREST 1 0.0000
986 DRUG WITHDRAWAL SYNDROME 1 0.0000
987 PRODUCT USE ISSUE 2 0.0000
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
989 ACUTE KIDNEY INJURY 1 0.0000